The discovery and development of novel immunomodulatory therapeutics from medicinal plants represents a critical frontier in pharmaceutical research, yet faces substantial challenges including compound complexity, limited bioavailability, and the difficulty of translating traditional knowledge into evidence-based medicine. This article examines the contemporary landscape of phytochemical-based immunomodulatory drug discovery, with particular emphasis on systematic approaches that bridge traditional botanical medicine and modern pharmaceutical science. The discussion encompasses advanced methodologies in target identification and validation, high-throughput screening platforms adapted for complex plant extracts, and lead optimization strategies that enhance pharmacological properties while maintaining bioactive integrity. Special attention is devoted to preclinical models that accurately predict human immune responses, translational strategies that facilitate clinical progression, and innovative clinical development paradigms including adaptive trial designs and biomarker-guided patient stratification. Technological enhancements, particularly computational modeling and artificial intelligence applications in predicting immunomodulatory activity and optimizing molecular structures, are explored as transformative tools in accelerating discovery timelines. The integration of these modern approaches has yielded promising therapeutic candidates, with several plant-derived immunomodulators advancing through clinical pipelines. However, persistent challenges remain, including standardization of botanical materials, regulatory pathway navigation, and ethical considerations surrounding traditional knowledge. This comprehensive review provides a roadmap for researchers and clinicians seeking to harness the immunomodulatory potential of medicinal plants through rigorous scientific methodology, ultimately contributing to the development of safe, effective, and accessible immune-targeted therapeutics for diverse patient populations.